Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Kits Eyecare Ltd T.KITS

Alternate Symbol(s):  KTYCF

Kits Eyecare Ltd. is a Canada-based provider of vertically integrated and digitally native eyecare platforms. The Company operates through the sale of eyewear products to consumers. It offers customers access to a selection of contact lenses and eyeglasses, including its own KITS-designed products, as well as an advanced suite of online vision tools. Its collections include South Beach, Little Italy, Trail Blazer, KITS x Vasuma and Apres. The Company's designer glasses and sunglasses, including Alexander Mcqueen, Armourx, Betsey Johnson, Bottega Veneta, Calvin Klein Carrera, David Beckham, Diesel, Dior, Emilio Pucci, Emporio Armani, Gucci, Hugo Boss, Jimmy Choo, Judith Leiber, Kits, Persol, Prada, Ray-Ban, Superdry, Tom Ford, Under Armour, And Versace.


TSX:KITS - Post by User

Post by nozzpackon Jan 10, 2023 9:57am
193 Views
Post# 35213159

Excellent Q4 Growth to $25 m ..Strong cash

Excellent Q4 Growth to $25 m ..Strong cash

 

ORIGINAL: KITS Eyecare Reports Strong Preliminary Fourth Quarter and Full Year 2022 Results

 

2023-01-10 09:29 ET - News Release

 

Revenue Growth Continued in Q4, Increasing 25% Year-over-Year and 9% Sequentially

Healthy Balance Sheet and Resilient Optical Market Has KITS Well-Positioned for 2023

VANCOUVER, BC, Jan. 10, 2023 /CNW/ - Kits Eyecare Ltd. (TSX: KITS) ("KITS" or the "Company"), Canada'sleading, vertically integrated eyecare platform, is providing selected preliminary unaudited results for its fourth quarter and full year ended December 31, 2022.

Preliminary Fourth Quarter and Full Year 2022 Financial and Operational Highlights

  • For Q4 2022, revenue grew to approximately $25 million, representing a 25% increase year-over-year and a 9% increase sequentially.
  • Repeat customers represented over 60% of revenue in Q4 2022.
  • For the full year 2022, revenue is expected to increase 9% to approximately $90 million compared to 2021, and a significant increase compared to 2019 pre-pandemic revenue of $36.8 million.
  • The Company's year-end cash balance remained healthy at approximately $19 million.
"In Q4, momentum continued to accelerate with revenue growing 25% year-over-year, as the optical industry remained resilient despite volatility in the broader consumer environment," said Roger Hardy, co-founder and CEO of KITS. "We have now grown revenue 145% since pre-pandemic levels in 2019, while adding significantly to the complexity and competitive moat of the offering. KITS has evolved from a digitally native retailer to a vertically integrated retail manufacturer. In addition, we are now a preferred partner to some of the leading insurance providers in the market, rounding out the third leg of the KITS eyecare competitive stool. The Company's growth accelerated in each of the past two quarters as the offering continued to gain traction in each segment."KITS anticipates reporting its fourth quarter and full year 2022 financial and operational results in early March 2023.About KITS
KITS is Canada's faste
<< Previous
Bullboard Posts
Next >>